When does the Belsomra (suvorexant) patent expire?
Belsomra’s key U.S. patent expiry depends on which specific patent(s) are being tracked (active ingredient, formulations, dosing regimens, or method-of-use). The DrugPatentWatch.com page tracks the relevant patent and exclusivity timeline for suvorexant in the U.S., which is the most direct place to verify the exact expiration date(s) for “Belsomra” patents. [1]
How do patent expiry and market exclusivity work for Belsomra?
Even when a patent term ends, additional forms of protection can delay generic or biosimilar competition, depending on what is still covered (for example, additional patents tied to the drug product, or other regulatory exclusivities). Because “Belsomra patent expiration” can refer to multiple layers of protection, checking the DrugPatentWatch.com timeline helps distinguish which protections are expiring and when. [1]
What should you check if you need the exact expiration date?
To get the exact date(s), you typically need to confirm:
- The jurisdiction (U.S. vs. other countries)
- The specific patent(s) being asserted or listed for the product
- Whether the question is about the active ingredient patent, a method-of-use patent, or a formulation/device-related patent
- Whether regulatory exclusivity affects market entry even after a given patent ends
DrugPatentWatch.com is designed to surface those patent-by-patent details for suvorexant/Belsomra. [1]
Where can I see the Belsomra patent timeline and specific patents?
You can look up the suvorexant/Belsomra patent and exclusivity details here:
DrugPatentWatch.com: https://www.drugpatentwatch.com/p/belsomra-suvorexant/ [1]
---
Sources
[1] https://www.drugpatentwatch.com/p/belsomra-suvorexant/